All News

2070 articles, sorted by publication time.

Biopharmaceuticals · global

After TREGZI, the Real Test for Treg Therapy Begins

The FDA’s first clearance of a regulatory T-cell therapy to reduce the risk of chronic graft-versus-host disease extends the treatment goal of allogeneic stem cell transplantation from “winning against cancer” to “rebuilding immune order”; but with limited source information, the magnitude of benefit, eligible populations, and clinical implementation still need to be clarified through review documents and follow-up data.

Biotechnology · global

Plant-Derived Prostate Drug Takes the Stage at BIO 2026 as Jyong Biotech Looks for the Next Clinical and Commercial Handoff

In a market where treatment options for benign prostatic hyperplasia are mature but unmet needs remain, Jyong Biotech is bringing its plant-derived drug candidate before international pharmaceutical companies. The focus of this meeting is not just a natural-products story, but whether partners can be convinced that it is developable, reviewable, and scalable.